Company news
Sol-Gel Technologies Ltd. news in 2025
Sol-Gel Technologies Ltd.'s news releases, calls and decks from 2025, newest first.
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
December 17, 2025
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 20, 2025
Sol-Gel Announces Health Canada Approval of EPSOLAY®
September 4, 2025
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
August 15, 2025
Sol-Gel Reports First Quarter 2025 Results
May 23, 2025
Sol-Gel Announces Reverse Share Split
May 1, 2025
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
April 17, 2025
Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects
February 3, 2025